CMA Investigation vs Private Enforcement United Kingdom: When to Defend, Settle or Bring a Claim (2026)

Every general counsel, founder or CFO facing a CMA investigation vs private enforcement United Kingdom decision confronts the same fork: do you cooperate with (or defend against) the Competition and Markets Authority’s public enforcement machinery, or do you launch, or respond to, a private damages claim through the courts? The answer shapes legal spend, management distraction, reputational exposure and, ultimately, the commercial outcome for years. With the 2026 opt-out collective actions regime review and a surge in follow-on damages litigation, the calculus has shifted materially, claimants have more routes, defendants face wider exposure, and the interaction between the two tracks demands a clear-eyed strategy from day one.

This article provides a dimension-by-dimension comparison, an anchor decision table and a prescriptive framework so you can choose the right path before you instruct counsel.

Option A: CMA Investigation and Public Enforcement

The CMA is the United Kingdom’s principal competition authority. It enforces the Competition Act 1998 (prohibitions on anticompetitive agreements under Chapter I and abuse of dominance under Chapter II) and conducts market studies and market investigations under the Enterprise Act 2002. Public enforcement is the CMA’s initiative, it decides which cases to pursue, informed by complaints, intelligence and its own monitoring.

Typical CMA pathways include:

• Behavioural (CA98) investigations. The CMA opens a formal case, issues information notices under section 26 of the Competition Act 1998, and may conduct dawn raids under sections 27–28. It can impose financial penalties of up to 10 % of worldwide group turnover for the year of the infringement.
• Market studies and market investigations. Under the Enterprise Act 2002, the CMA examines whether market features prevent, restrict or distort competition. Remedies can include structural orders, behavioural undertakings and recommendations to government.
• Consumer enforcement. The CMA can pursue direct consumer enforcement, including seeking court orders and accepting undertakings to secure compliance with consumer protection legislation.

Where the CMA acts, respondents face compulsory information-gathering (backed by daily penalties for non-compliance), reputational harm from public announcements, and the risk of substantial fines. However, complainants and victims cannot control the CMA’s timetable, priorities or remedies. Public enforcement suits situations where the infringement is systemic, individual claimants lack the resources to litigate, or the conduct requires regulatory intervention, such as market-wide remedies, that no private claim can deliver. The CMA’s healthcare and digital-markets investigations illustrate this: structural market failures required investigation-level remedies beyond what any single claimant could achieve in court.

Option B: Private Enforcement and Damages Claims

Private enforcement allows businesses and consumers harmed by anticompetitive conduct to claim compensation directly. Claims are brought in the Competition Appeal Tribunal (CAT) or the High Court, either as stand-alone actions (where no prior CMA finding exists) or as follow-on actions (relying on a CMA or European Commission infringement decision as binding proof of breach).

Since the Consumer Rights Act 2015 introduced opt-in and opt-out collective proceedings in the CAT, group claims have become a prominent feature of UK competition damages UK litigation. A representative claimant, often a consumer body or purpose-formed class representative, can bring proceedings on behalf of an entire class without individual class members needing to take action. Early indications suggest the 2026 reforms will widen access to this mechanism further.

Key features of the private enforcement route:

• Forum choice. Claimants may bring individual actions in the High Court or the CAT. Collective proceedings (opt-in or opt-out) are available only in the CAT.
• Funding. Third-party litigation funding, conditional fee arrangements (CFAs) and after-the-event (ATE) insurance have transformed claimant economics, many claims now proceed with no upfront cost to the claimant class.
• Remedies. Compensatory damages (including compound interest), injunctions and declaratory relief. Unlike CMA proceedings, the private route puts money directly into harmed parties’ hands.
• Burden of proof. The claimant must prove breach and causation on the balance of probabilities. In follow-on cases, the CMA’s infringement decision is binding, but claimants must still establish causation and quantum.

Private enforcement suits claimants who have suffered quantifiable loss, want monetary compensation and are prepared (or funded) to litigate. It is particularly attractive where a CMA finding already exists, where the CMA has declined to act, or where the claimant needs injunctive relief faster than the regulator can deliver.

CMA Investigation vs Private Enforcement, Side-by-Side Comparison

Quick-take recommendations from the comparison:

• If you need structural market change (behavioural remedies, market orders), only the CMA route delivers that.
• If you need money in your pocket, compensatory damages, private enforcement is the only path.
• If a CMA decision already exists, a follow-on private claim dramatically reduces your evidential burden on breach.
• If you are a defendant, managing both tracks simultaneously is the highest-cost, highest-risk scenario, early settlement evaluation is critical.

Dimension-by-Dimension Analysis: CMA vs Private Action

Costs and Funding

Cost is often the first question for both respondents and prospective claimants. The two routes create very different financial profiles, and the interaction between them can multiply exposure for defendants.

For claimants, the rise of third-party litigation funding has transformed the economics of competition damages UK claims. Funders typically take a percentage of any recovery, but the claimant bears no upfront cost. For defendants, the critical insight is that a CMA investigation and a parallel private claim can run simultaneously, doubling advisory spend and management distraction. Where both tracks are live, early settlement analysis is essential to contain total exposure.

Timing and Procedural Steps

Timing drives strategy. A typical CMA behavioural investigation progresses through initial assessment, formal investigation (with information notices and possible dawn raids), a statement of objections, provisional findings, representations and a final decision. This process commonly takes one to three years. Market investigations operate under a statutory 18-month timetable under the Enterprise Act 2002, extendable by six months.

Private claims follow civil litigation timelines: pre-action correspondence, issue of proceedings, disclosure, expert evidence, trial and judgment. Individual claims in the CAT or High Court typically resolve within two to four years. Collective proceedings in the CAT tend to take three to five years or longer, given the additional certification stage and complexity of class-wide quantum assessment. Where a claimant waits for a CMA infringement decision before bringing a follow-on claim, the total elapsed time from anticompetitive conduct to damages award can exceed seven years.

The practical consequence: claimants who can fund a stand-alone action may reach resolution faster than those who wait for CMA findings. Defendants facing a live CMA investigation should model the follow-on claim timeline from the outset.

Liability, Remedies and Enforceability

The CMA and the civil courts offer fundamentally different remedies. Understanding the distinction is essential to choosing the right route, or managing both.

• CMA remedies. Financial penalties (up to 10 % of worldwide group turnover), directions to modify or cease conduct, market investigation remedies (including structural remedies such as divestiture under the Enterprise Act 2002), and undertakings in lieu of orders. The CMA can also pursue criminal prosecution for the cartel offence under section 188 of the Enterprise Act 2002.
• Private remedies. Compensatory damages (including compound interest), injunctions preventing ongoing or future anticompetitive conduct, and declaratory relief. Damages are assessed on a “but-for” basis, what the claimant’s position would have been absent the infringement.
• Follow-on interaction. A CMA infringement decision is binding in subsequent private proceedings as proof that the breach occurred. However, claimants must still prove causation (that the infringement caused their specific loss) and quantum (the amount of that loss). This evidential advantage is significant but does not guarantee recovery.

Enforceability differs in practice. CMA fines are collectible as civil debts and CMA orders carry the immediate weight of regulatory authority. Court and CAT judgments are enforceable through standard civil enforcement mechanisms, but cross-border enforcement against foreign defendants may require additional procedural steps.

Disclosure, Privilege and Regulatory Burden

The CMA’s investigative powers create a fundamentally different disclosure environment from civil litigation. Under section 26 of the Competition Act 1998, the CMA can require the production of documents and information by way of formal notice, non-compliance is a criminal offence and may attract daily financial penalties. Dawn raids under sections 27 and 28 allow CMA officers to enter premises and seize documents, including electronic records.

For defendants, this compelled disclosure can be strategically damaging: documents produced to the CMA may later become available to private claimants through the CAT or court disclosure process. Managing privilege is therefore critical from the moment a CMA investigation is anticipated. Key practical rules:

• Legal professional privilege attaches to communications made for the purpose of obtaining legal advice, but in-house lawyer communications may face closer scrutiny than those with external counsel.
• Litigation privilege requires that litigation be reasonably in prospect and that the dominant purpose of the document be preparation for that litigation.
• Waiver of privilege in one context (e.g., CMA engagement) can extend to related proceedings, careful management of what is disclosed, and to whom, is essential.

Tax Implications of Damages and Settlements

The tax treatment of competition damages and settlement payments varies according to the nature of the payment. Compensatory damages received for loss of trading profits are generally treated as taxable trading receipts. Capital payments, for example, sums compensating for damage to a capital asset or goodwill, may be treated differently. The characterisation of a settlement sum depends on what it replaces, not on how the parties label it.

Tax should be treated as a material factor in any settlement negotiation. Both claimants and defendants should obtain specific tax advice before agreeing settlement terms, as the net value of a settlement can differ substantially depending on the HMRC treatment applied. Specialist tax counsel should be instructed alongside competition counsel where the sums involved are significant.

What Changes in 2026: Private Enforcement Reform

The year 2026 marks an inflection point for private damages claims 2026 strategy. The UK government’s review of the opt-out collective actions regime has prompted a formal CMA response, and industry observers expect the resulting reforms to widen access to collective proceedings in the CAT. The CMA’s 2026 response to the opt-out review signals support for streamlining the certification process and clarifying the framework for distribution of damages in collective settlements.

The likely practical effects of private enforcement reform 2026 include:

• Lower barriers for claimant classes. If certification thresholds are clarified or relaxed, more collective claims will proceed, increasing the volume and value of follow-on and stand-alone damages actions.
• Greater funder appetite. Litigation funders are already increasing their allocation to UK competition claims. Clearer rules and faster certification reduce funder risk and improve expected returns.
• Pressure on defendants to settle earlier. As collective claims become more viable, defendants face a growing incentive to settle before class certification, at which point damages exposure and legal costs escalate rapidly.

For defendants with live CMA exposure, the reform trajectory means that the cost of inaction is rising. For claimants, the window for launching well-funded collective proceedings has never been wider. Both sides should reassess their enforcement strategy in light of the 2026 landscape.

Decision Framework: Settle or Litigate Your Competition Claim

This is the central question: given your circumstances, which route should you take? The answer depends on your role (claimant or defendant), the strength of the evidence, the availability of a CMA finding, and your commercial priorities. Use the framework below to identify the right path.

Choose CMA / public enforcement when:

• The infringement is systemic or market-wide and requires structural remedies (divestiture, market orders) that no private action can deliver.
• You are a complainant without the resources or appetite to fund private litigation, even with third-party funding.
• You need the CMA’s compulsory information-gathering powers to uncover evidence you cannot obtain through civil disclosure.
• Criminal prosecution of individuals involved in a cartel is a desired outcome, only the CMA can bring the cartel offence under section 188 of the Enterprise Act 2002.
• You want to establish a binding infringement decision that will support future follow-on damages claims by you or others.
• The anticompetitive conduct affects consumers broadly and a consumer redress or undertakings outcome would serve the public interest.

Choose private enforcement when:

• You have suffered quantifiable financial loss and your primary objective is monetary compensation.
• A CMA infringement decision already exists, making a follow-on claim the lower-risk litigation path.
• The CMA has declined to investigate, deprioritised your complaint, or is unlikely to act within an acceptable timeframe.
• You need an injunction to stop ongoing anticompetitive conduct faster than the CMA’s investigation timetable allows.
• Litigation funding is available and your claim has the scale and merits profile to attract funder support.
• You want control over the timetable, the litigation strategy and the settlement terms, none of which a CMA complainant has in public enforcement.

Consider settlement when:

• A CMA investigation is live and the defendant’s costs are escalating, settling the associated private claim removes one front of exposure.
• Class certification in collective proceedings is imminent, and post-certification damages exposure will increase substantially.
• Both sides have exchanged sufficient evidence to assess merits and quantum realistically.
• The defendant wants to include confidentiality terms that would not be achievable after a public trial judgment.
• The claimant’s litigation funder is applying pressure for a timely return, making a negotiated outcome attractive.
• Reputational damage from a prolonged public trial outweighs the financial difference between the settlement offer and likely judgment.

When to Hire a Competition Lawyer

The decision between CMA engagement and private enforcement is not one to navigate without specialist counsel. Certain triggers demand immediate legal advice, delay can be irreversible. Engage a competition lawyer when:

• You receive a CMA information notice or dawn-raid warrant. Compliance is mandatory and errors are criminal offences. Counsel must review the scope, manage privilege and coordinate the response from day one.
• You discover internal evidence of cartel conduct or anticompetitive agreements. Leniency applications to the CMA are time-sensitive, the first applicant receives immunity from fines, and later applicants receive progressively smaller reductions. Delay forfeits the advantage.
• You receive a pre-action letter threatening private competition damages. Early merits and quantum assessment can determine whether to defend, settle or counterclaim, and shapes the defence budget before costs escalate.
• Your business has significant cross-border exposure. Parallel investigations or claims in multiple jurisdictions require coordinated privilege strategy and consistent factual positions across regulators and courts.
• Directors face personal liability risk. The cartel offence under section 188 of the Enterprise Act 2002 carries a maximum sentence of five years’ imprisonment. Where individual criminal exposure is possible, personal legal representation, separate from the company’s counsel, is essential.

Conclusion

The choice between a CMA investigation vs private enforcement United Kingdom is not abstract, it determines your costs, your timeline, your remedies and your commercial outcome. Public enforcement delivers market-wide change and regulatory penalties but leaves the claimant without compensation and without control. Private enforcement puts money in the hands of those harmed but requires litigation funding, evidential rigour and patience. The 2026 reforms are tilting the balance toward private claims: collective proceedings are becoming more accessible, funders are more willing to back competition cases, and defendants face growing pressure to settle early.

Whether you are a business that has suffered anticompetitive harm, a company facing a CMA probe, or a board evaluating settlement terms, the decision demands specialist competition counsel, engaged early, before the key strategic choices are foreclosed.

Sources

1. GOV.UK, Private actions and public enforcement
2. GOV.UK, Service of documents on the CMA in court proceedings
3. CMA response, Opt-out collective actions regime review (2026)
4. Competition Appeal Tribunal, The Relationship between Public and Private Enforcement (Ashurst/Burrows)
5. Slaughter and May, Private Enforcement of Competition Law in the UK
6. LexisNexis, CMA behavioural investigation process
7. FTI Consulting, UK Competition Enforcement, Public and Private (Apr 2026)
8. Richardson Lissack, A Guide to CMA Investigations
9. GOV.UK, How the CMA uses its direct consumer enforcement powers
10. Competition Act 1998
11. Enterprise Act 2002
12. CMA Blog, Private healthcare professionals and competition rules